Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization

Genes Chromosomes and Cancer

Volumn 35, Issue 1, 2002, Pages 66-73

  Laitinen, Sari ^a   Karhu, Ritva ^a   Sawyers, Charles L ^b   Vessella, Robert L ^c   Visakorpi, Tapio ^a,d  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ANDROGEN RELEASE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CHROMOSOME 13Q; CHROMOSOME 18Q; CHROMOSOME 2Q; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME XQ; COLOR; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE MODEL; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN MODIFICATION; XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; CELL CULTURE; CHROMOSOME DELETION; CLASSIFICATION; COMPARATIVE STUDY; GENE AMPLIFICATION; GENETICS; METHODOLOGY; MOUSE; MOUSE MUTANT; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY; PROSTATE TUMOR;

ANIMAL; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; COMPARATIVE STUDY; GENE AMPLIFICATION; HUMAN; MALE; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NUCLEIC ACID HYBRIDIZATION; PROSTATIC NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; ANIMALS; HUMANS;

EID: 0036022071     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10097     Document Type: Article

References (36)

1. Identification of genetic markers for prostatic cancer progression
2. IPM-FISH, a new M-FISH approach using IRS-PCR painting probes: Application to the analysis of seven human prostate cell lines
3. Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and tissue microarrays
4. Chromosome identity of human prostate cancer cell lines, PC-3 and pPC-1
5. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping
6. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process
7. Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23
8. Molecular genetics of prostate cancer
9. DNA ploidy by image analysis of individual foci of prostate cancer: A preliminary report
10. Chromosome arm painting probes
11. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer
12. Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity, and metastatic potential in a prostate cancer model
13. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization
14. Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization
15. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
16. Chromosome arm-specific multicolor FISH
17. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice
18. Molecular cytogenetic studies of a serially transplanted primary prostatic carcinoma xenograft (CWR22) and four relapsed tumors
19. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer
20. CWR22: The first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar
21. Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization
22. Genetic alterations in hormone-refractory recurrent prostate carcinomas
23. Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping
24. 5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines
25. WISH-PC2: A unique xenograft model of human prostatic small cell carcinoma
26. Xenografts of primary human prostatic carcinoma
27. Xenograft models and the molecular biology of human prostate cancer
28. A new human prostate carcinoma cell line, 22Rv1
29. The use of multicolor fluorescence technologies in the characterization of prostate carcinoma cell lines: A comparison of multiplex fluorescence in situ hybridization and spectral karyotyping data
30. TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin
31. Development of seven new human prostate tumor xenograft models and their histopathological characterization
32. In vivo amplification of the androgen receptor gene and progression of human prostate cancer
33. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization
34. CWR22: Androgen-dependent xenograft model derived from a primary human prostatic carcinoma
35. Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts